A Phase I Study of TS-142 in Non-Elderly Healthy Participants (Repeated Doses) (A Multiple Ascending Dose Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of TS-142 in Non-Elderly Participants)
Latest Information Update: 25 Nov 2019
At a glance
- Drugs Vornorexant (Primary)
- Indications Insomnia
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Taisho Pharmaceutical
Most Recent Events
- 25 Nov 2019 New trial record